Finance

Beta
Lists
TMAN:BKK
T Man Pharmaceutical PCL
THB 10.80
+1.89%
(+0.20) 1D
Jun 24, 4:40:00 PM GMT+7  ·   THB
All symbols
SymbolPriceChange% Change
Generating top insights for TMAN...
Open
THB 10.70
High
THB 10.80
Low
THB 10.70
Mkt. cap
4.32B
Avg. vol.
193.92K
Volume
105.22K
Dividend
5.19%
Quarterly dividend
THB 0.14
Ex-dividend date
May 8, 2026
P/E ratio
8.38
52-wk high
THB 13.60
52-wk low
THB 9.95
EPS
THB 1.29
Shares outstanding
400.00M
No. of employees
960
Open
THB 10.70
High
THB 10.80
Low
THB 10.70
Mkt. cap
4.32B
Avg. vol.
193.92K
Volume
105.22K
Dividend
5.19%
Quarterly dividend
THB 0.14
Ex-dividend date
May 8, 2026
P/E ratio
8.38
52-wk high
THB 13.60
52-wk low
THB 9.95
EPS
THB 1.29
Shares outstanding
400.00M
No. of employees
960
News stories
From sources across the web
About T Man Pharmaceutical PCL
CEO-
Employees960
Founded1972
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in THB
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in THB
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
535.52M
661.41M
730.15M
633.71M
Cost of goods sold
260.48M
377.69M
392.07M
338.37M
Cost of revenue
260.48M
377.69M
392.07M
338.37M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
141.36M
143.41M
175.59M
151.39M
Operating expense
143.60M
145.32M
177.27M
150.88M
Total operating expenses
404.07M
523.02M
569.34M
489.25M
Operating income
131.45M
138.40M
160.81M
144.46M
Other non operating income
-
-
-
-
EBT including unusual items
123.90M
131.64M
212.45M
139.82M
EBT excluding unusual items
123.90M
131.64M
155.00M
139.82M
Income tax expense
17.12M
19.04M
30.67M
25.18M
Effective tax rate
13.82%
14.47%
14.44%
18.01%
Other operating expenses
-
-
-
-
Net income
106.78M
112.60M
181.79M
114.63M
Net profit margin
19.94%
17.02%
24.90%
18.09%
Earnings per share
-
-
0.46
0.29
Interest and investment income
-
-
-
-
Interest expense
-7.55M
-6.76M
-5.81M
-4.64M
Net interest expenses
-7.55M
-6.76M
-5.81M
-4.64M
Depreciation and amortization charges
-
-
-
-
EBITDA
162.43M
168.50M
185.85M
182.21M
Gain or loss from assets sale
-15.00K
-
-195.74K
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more